Herpes zoster of the maxillary branch of the trigeminus nerve

Sato, Mitsunobu; Urade, Masahiro; Shirasuna, Kanemitsu; Yura, Yoshiaki; Yoshida, Hideo; Yanagawa, Tetsuo; Morimoto, Manabu; Kobayashi, Atsushi; Hamamura, Yasushi; Kubo, Kazuko; Miyazaki, Tadashi

doi:10.1016/s0300-9785(79)80011-3

Cited by 6 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One possibility might rest in VZV viremia. Infectious VZV has been recovered from blood mononuclear cells (MNCs) of immunosuppressed patients with cancer 2-6 days after zoster [10], VZV has been isolated from the blood of an immunocompetent patient with zoster [11], and VZV DNA can be found in blood MNCs 1-23 days after zoster [12,13]. Another possibility is that VZV reactivated from geniculate ganglia simultaneously with VZV reactivation from ganglia in the dermatome where zoster occurred.…”

mentioning

confidence: 99%

Varicella‐Zoster Virus in the Saliva of Patients with Herpes Zoster

Mehta¹,

Tyring

Gilden

et al. 2008

J INFECT DIS

View full text Add to dashboard Cite

Fifty-four patients with herpes zoster were treated with valacyclovir. On treatment days 1, 8, and 15, pain was scored and saliva examined for varicella-zoster virus (VZV) DNA. VZV DNA was found in every patient the day treatment was started and later disappeared in 82%. There was a positive correlation between the presence of VZV DNA and pain and between VZV DNA copy number and pain (P <.0005). VZV DNA was present in 1 patient before rash and in 4 after pain resolved and was not present in any of 6 subjects with chronic pain or in 14 healthy subjects. Analysis of human saliva has potential usefulness in the diagnosis of neurological disease produced by VZV without rash.

show abstract

mentioning

confidence: 99%